• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 3. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 4. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 5. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Comprehensive Guide to 4-(Methylamino)butanoic Acid Hydrochloride (CAS No. 6976-17-6): Properties, Applications, and Market Insights

4-(Methylamino)butanoic acid hydrochloride (CAS No. 6976-17-6) is a chemically modified derivative of gamma-aminobutyric acid (GABA), a well-known neurotransmitter. This compound has garnered significant attention in both pharmaceutical research and biochemical applications due to its unique structural properties and potential therapeutic benefits. In this article, we delve into the chemical characteristics, synthesis methods, applications, and emerging trends surrounding this compound, while addressing frequently searched queries in the scientific community.

The molecular formula of 4-(methylamino)butanoic acid hydrochloride is C5H12ClNO2, with a molecular weight of 153.61 g/mol. Its structure features a methylamino group attached to the four-carbon backbone of butanoic acid, making it a valuable intermediate in organic synthesis. Researchers often explore its role in modulating neurotransmitter activity, particularly in studies related to neurological disorders and cognitive health—topics that align with trending searches in medical and biochemical fields.

One of the most searched questions about 4-(methylamino)butanoic acid hydrochloride is its solubility and stability. This compound is highly soluble in water and polar solvents, which enhances its applicability in drug formulation and laboratory research. Its hydrochloride salt form improves stability, making it suitable for long-term storage and experimental use. Additionally, its role in peptide synthesis and enzyme inhibition studies has been a focal point in recent publications.

From an industrial perspective, the demand for 4-(methylamino)butanoic acid hydrochloride is rising due to its potential in developing novel therapeutics. Pharmaceutical companies are investigating its efficacy in addressing conditions like anxiety, depression, and neurodegenerative diseases—topics frequently queried in AI-driven research platforms. The compound’s ability to cross the blood-brain barrier further amplifies its relevance in central nervous system (CNS) drug development.

In the realm of biochemical research, this compound is often compared to GABA analogs like pregabalin and gabapentin, which are widely prescribed for neuropathic pain. Such comparisons are common in academic searches, highlighting the need for detailed explanations of its mechanism of action. Unlike traditional GABAergic drugs, 4-(methylamino)butanoic acid hydrochloride exhibits a unique binding affinity, making it a subject of ongoing preclinical studies.

Market trends indicate a growing interest in custom synthesis and contract manufacturing of this compound, particularly for research institutions and biotech firms. Analysts attribute this trend to the increasing focus on personalized medicine and targeted drug delivery systems. Furthermore, regulatory approvals for GABA-related compounds have spurred investments in derivatives like 4-(methylamino)butanoic acid hydrochloride, as noted in recent industry reports.

For laboratory professionals, handling and storage guidelines are critical. The compound should be stored in a cool, dry place, away from direct sunlight, to maintain its integrity. Safety data sheets (SDS) recommend standard precautions, such as wearing gloves and goggles, when handling 4-(methylamino)butanoic acid hydrochloride—a detail often overlooked in search queries but essential for practical applications.

Looking ahead, the future of 4-(methylamino)butanoic acid hydrochloride appears promising, with advancements in computational chemistry and AI-driven drug discovery accelerating its exploration. As researchers continue to uncover its full potential, this compound is poised to play a pivotal role in next-generation neuropharmacology and biomedical innovations.

• 1215511-11-7(N-Methyl-4-aminobutyric Acid-d3)
• 85331-42-6(1-Butanaminium, 4-carboxy-N,N,N-trimethyl-, chloride)
• 25726-28-7(5-(Dimethylamino)pentanoic acid hydrochloride)
• 69954-66-1(4-(dimethylamino)butanoic acid;hydrochloride)
• 7408-81-3(12-(Methylamino)dodecanoic Acid)
• 91485-20-0(Butanoic acid, 4-(methylamino)-, lithium salt (1:1))
• 6249-56-5(γ-Butyrobetaine Hydrochloride)
• 1119-48-8(N-Methyl-4-aminobutyric Acid)
• 6828-42-8(4,4-bis(n,n-dibutyric acid))
• 85806-16-2(1-Pentanaminium, 5-carboxy-N,N,N-trimethyl-, chloride)